GLP-1 weight loss drugs continue to reveal benefits well beyond the scale. New research suggests medications sold under brand names including Ozempic, Wegovy, and Mounjaro may improve testosterone levels and sperm quality in men — adding male fertility to a growing list of unexpected health benefits that already includes reduced dementia risk, improved ADHD symptoms, and lower breast cancer risk in women.
Researchers at University Hospitals Coventry and Warwickshire and Warwick Medical School in the UK believe the benefit stems not from the drugs directly affecting fertility, but from the weight loss they produce. Obesity is closely linked to both low testosterone and poor sperm quality, creating a cycle that is notoriously difficult to break without intervention.
How Obesity Damages Male Fertility
The relationship between excess weight and reduced fertility works through several overlapping mechanisms. Fat tissue contains an enzyme called aromatase, which converts testosterone into estrogen. Over time, elevated aromatase activity disrupts signalling between the brain and testicles, gradually reducing the body’s overall testosterone production. Obesity is also associated with reduced production of sex hormone-binding globulin, the protein responsible for carrying testosterone through the bloodstream.
When the body produces insufficient testosterone, the condition is known as hypogonadism. The standard treatment has long been testosterone replacement therapy, typically delivered through injection. But TRT carries real limitations. Men at risk of prostate cancer or heart disease cannot safely use it. Even for those who can, it carries risks including worsened sleep apnea, acne, and — counterintuitively for men hoping to preserve fertility — reduced sperm production and testicular shrinkage.
“This supports a shift away from prescribing testosterone replacement in men with obesity and low testosterone and toward treating the underlying cause — excess weight and poor metabolic health — which can naturally restore hormone levels and preserve fertility,” said study author Dr Pratibha Natesh of Warwick Medical School.
What the Research Actually Found
The research team examined the effects of three GLP-1 medications — dulaglutide (Trulicity), liraglutide (Victoza and Saxenda), and semaglutide (Ozempic, Wegovy, and Rybelsus) — in men aged 18 to 65.
Liraglutide produced the most significant results, increasing testosterone levels alongside luteinising hormone, which stimulates testosterone production, and follicle-stimulating hormone, which stimulates sperm production. The drug also improved both sperm concentration and total sperm count. Semaglutide improved sperm morphology — the proportion of normally shaped sperm — while maintaining levels of two key sex hormones. Dulaglutide showed no significant change in reproductive hormone levels, sexual function scores, or semen quality.
Researchers were careful to frame the findings as an indirect benefit of weight loss rather than evidence that GLP-1 drugs should be prescribed specifically for fertility purposes. “Improving metabolic health can have positive effects far beyond weight alone,” Natesh said.
The research team also cautioned that the evidence base remains limited, with results varying across different drugs and patient populations. Larger studies, they say, will be needed before the full relationship between GLP-1 medications and male fertility is properly understood. As with previous findings on dementia, depression, and cancer risk, this is one more data point in a rapidly expanding picture of what these drugs may be capable of — though specialists continue to emphasise that more rigorous, long-term research is essential before drawing firm conclusions.
This article discusses medical and health research. If you have personal concerns about fertility, testosterone levels or weight management, please consult a qualified healthcare provider for guidance specific to your situation.
Stay informed. Subscribe to the JournalTodays Newsletter for the latest health news, medical research, and wellness updates delivered straight to your inbox.
